519 672 2121
Close mobile menu

Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.

News & Views

Blog

The more you understand, the easier it is to manage well.

View Blog

US court rejects Johnson & Johnson bankruptcy bid

On March 31, 2025, a US bankruptcy court rejected another plan by a Johnson & Johnson s…

Election Day and employers: Legal obligations you can’t ignore

As Canadians gear up to cast their ballots in the upcoming federal general election on Monda…